SCHEMBL28061000

SCHEMBL28061000

[CH2]c1ccc([N+](=O)[O-])c(Oc2c(C)cccc2C)c1

nearest known ligand 0.44

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 4/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ HSD17B10 Q99714 1/20 0.42
▸ HSPB1 P04792 1/20 0.40
▸ TDP1 Q9NUW8 5/20 0.40
▸ ALDH1A1 P00352 4/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ CYP3A4 P08684 1/20 0.38
▸ HTR6 P50406 1/20 0.37
▸ MAPT P10636 1/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10422388 0.83 TSHR (0.50) TSHRSMN1; SMN2HSD17B10HSPB1TDP1
SCHEMBL16335619 0.77 MAPT (0.50) TSHRSMN1; SMN2TDP1ALDH1A1L3MBTL1
SCHEMBL423843 0.76 ALDH1A1 (0.56) TSHRHSD17B10TDP1ALDH1A1L3MBTL1
SCHEMBL10422347 0.74 TSHR (0.60) TSHRSMN1; SMN2HSD17B10HSPB1TDP1
SCHEMBL3029646 0.73 MAPT (0.56) TSHRSMN1; SMN2HSD17B10TDP1ALDH1A1
SCHEMBL28054673 0.73 TSHR (0.49) TSHRSMN1; SMN2HSD17B10TDP1ALDH1A1
SCHEMBL28078625 0.72 PDK1 (0.47) TSHRSMN1; SMN2TDP1ALDH1A1L3MBTL1
SCHEMBL16952275 0.72 MAPT (0.57) SMN1; SMN2TDP1ALDH1A1L3MBTL1CYP3A4
SCHEMBL3030569 0.71 ALDH1A1 (0.53) TSHRHSPB1TDP1ALDH1A1CYP3A4
SCHEMBL11592413 0.71 ALDH1A1 (0.39) TSHRSMN1; SMN2TDP1ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105531273-A Bromodomain inhibitors ABBVIE INC 2016-04-27 — — CN disclosed
CN-105518007-A BROMODOMAIN INHIBITORS ABBVIE INC 2016-04-20 — — CN disclosed
Send feedback